Natus Medical Cuts Q2 Revenue Guidance - Quick Facts

(RTTNews) - Natus Medical Inc. (BABY) announced that it lowered its second quarter of 2013 revenue guidance to a range of $81 million - $82 million from the previous estimate of $86 million - $90 million. Analysts polled by Thomson Reuters expect the company to report revenues of $88.58 million for the second-quarter. Analysts' estimates typically exclude special items.

"Weakness in our International markets, particularly Europe, led to an unexpected decline in revenue late in the second quarter," said Jim Hawkins, President and Chief Executive Officer of the Company. "Domestic revenue was within our expectations."

The company noted that it will update its third quarter and full year 2013 financial guidance during its second quarter financial results conference call on August 1, 2013.

In the pre-market trade, BABY is currently trading at $13.39, down $0.90 or 6.27%.